The Yale-Drug use, Addiction and HIV Research Scholar program (DAHRS) began in 2013 with the aim of training a group of diverse young faculty from multiple medical specialties to meet the critical need to develop a pool of highly trained clinician scholars to conduct biomedical, behavioral and clinical research related to drug use, addiction, and HIV prevention and treatment in general medical settings. Patients with substance use disorders often receive medical care in general medical settings such as primary care clinics and emergency departments; HIV, adolescent and women's health and other specialty clinics; presenting with a complex array of acute consequences and complications (e.g. intoxication, overdose, withdrawal, and trauma) of substance use and chronic conditions such as pain, HIV disease, hepatitis, pulmonary and cardiac disease. Patients are increasingly presenting to these settings for the prevention and treatment of addiction itself. The Yale-DAHRS program provides a comprehensive three year post-doctorate, interdisciplinary Mentored Career Development Program that incorporates a robust didactic research curriculum leading to a Masters in Health Science degree, mentored research and training in topics related to Addiction Medicine to: [Aim 1] Develop clinician scientists with the knowledge, skills, and ability to become independent investigators, generating findings of practical value with significant impact to improve health in patients with and at risk for drug use, addiction, and HIV; [Aim 2] Develop future leaders by providing Scholars with leadership skills and creating individualized programs to ensure success in leading multidisciplinary research teams in studying drug use, addiction and HIV, and implementation and integration of research findings into general medical settings; and [Aim 3] Enhance the diversity of drug use, addiction, and HIV researchers. Supporting the careers of women and under-represented minority faculty enhances the diversity of investigators and research topics, broadens perspectives in setting research priorities, increases clinical trial participation, and expands knowledge. To date, our program has demonstrated success capitalizing on the synergies of established training and clinical programs at Yale and our community partners, and the experiences offered by our seasoned, diverse group of interdisciplinary core faculty, mentors and advisory committee. We have enrolled five Scholars (four women) from the fields of internal medicine, pediatrics, emergency medicine, obstetrics and gynecology and pulmonary medicine. All three graduates accepted academic research positions. One has received independent NIDA R01 funding and is co-investigator on two NIH funded grants; one received PI pilot funding from two institutional NIH grants and is awaiting an R21 NIH review; the third is a co-investigator on NIDA and CDC grants and is awaiting review on two grants. All have published in high impact journals and textbooks and are emerging leaders in their clinical specialties. This first time renewal supports four Scholars, benefiting from the iterative changes we have made to improve the program, adding to the next generation of investigators.

Public Health Relevance

Addiction is a major cause of morbidity and mortality and patients with or at risk for substance use disorders typically receive care in general medical settings such as emergency departments and primary care, HIV, adolescent and women's health clinics. Patients often present with a complex array of acute and chronic complications of addiction (e.g. Overdose, HIV infection) and other high risk conditions such as chronic pain, thus these settings offer a critical opportunity to prevent and treat addiction. This proposal seeks to train early career investigators with backgrounds in general medical disciplines such as internal medicine, pediatrics, family medicine, emergency medicine, and obstetrics and gynecology in order to enhance the prevention, identification, and treatment of addiction in general medical settings.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Physician Scientist Award (Program) (PSA) (K12)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Duffy, Sarah Q
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Emergency Medicine
Schools of Medicine
New Haven
United States
Zip Code
Gariepy, Aileen M; Hieftje, Kimberly; Pendergrass, Tyra et al. (2018) Development and Feasibility Testing of a Videogame Intervention to Reduce High-Risk Sexual Behavior in Black and Hispanic Adolescents. Games Health J :
Gaither, Julie R; Gordon, Kirsha; Crystal, Stephen et al. (2018) Racial disparities in discontinuation of long-term opioid therapy following illicit drug use among black and white patients. Drug Alcohol Depend 192:371-376
Hawk, Kathryn; D'Onofrio, Gail (2018) Emergency department screening and interventions for substance use disorders. Addict Sci Clin Pract 13:18
Camenga, Deepa; Gutierrez, Kevin M; Kong, Grace et al. (2018) E-cigarette advertising exposure in e-cigarette naïve adolescents and subsequent e-cigarette use: A longitudinal cohort study. Addict Behav 81:78-83
Loree, Amy M; Gariepy, Aileen; Ruger, Jennifer Prah et al. (2018) Postpartum Contraceptive use and Rapid Repeat Pregnancy Among Women who use Substances. Subst Use Misuse 53:162-169
McNamara, Blair C; Cutler, Abigail; Lundsberg, Lisbet et al. (2018) ""I'm used to doing it by myself"": exploring self-reliance in pregnancy. BMC Pregnancy Childbirth 18:393
Barry, Declan T; Marshall, Brandon D L; Becker, William C et al. (2018) Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care. Drug Alcohol Depend 191:348-354
Edelman, E Jennifer; Moore, Brent A; Holt, Stephen R et al. (2018) Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial. AIDS Behav :
Baldassarri, Stephen R; Bernstein, Steven L; Chupp, Geoffrey L et al. (2018) Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study. Addict Behav 80:1-5
Lundsberg, Lisbet S; Peglow, Stephanie; Qasba, Neena et al. (2018) Is Preconception Substance Use Associated With Unplanned or Poorly Timed Pregnancy? J Addict Med 12:321-328

Showing the most recent 10 out of 50 publications